Go-DACT proof on concept results: golimumab + MTX superior to monotherapy MTX in PsA dactylitis. https://t.co/dEGnjiuGZf #ACR19 @RheumNow abs#2876
Links:
Go-Dact: A Phase 3b Randomized Double-Blind Placebo-Controled Proof-Of-Concept …
http://ow.ly/ZPvO50x3BCr
Nov-13-2019
